TY  - GEN
AU  - Mayr,Christian
AU  - Wagner,Andrej
AU  - Loeffelberger,Magdalena
AU  - Bruckner,Daniela
AU  - Jakab,Martin
AU  - Berr,Frieder
AU  - Di Fazio,Pietro
AU  - Ocker,Matthias
AU  - Neureiter,Daniel
AU  - Pichler,Martin
AU  - Kiesslich,Tobias
TI  - The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
SN  - 1949-2553
PY  - 2016///1107
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Biliary Tract Neoplasms
KW  - genetics
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Cell Survival
KW  - Cisplatin
KW  - Dose-Response Relationship, Drug
KW  - Drug Synergism
KW  - Flow Cytometry
KW  - G1 Phase Cell Cycle Checkpoints
KW  - Gene Expression Regulation, Neoplastic
KW  - Heterocyclic Compounds, 2-Ring
KW  - Humans
KW  - Immunohistochemistry
KW  - Neoplastic Stem Cells
KW  - Polycomb Repressive Complex 1
KW  - antagonists & inhibitors
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Thiazoles
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.6378
ER  -